National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 10023 [2017-02620]
Download as PDF
Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices
• Low toxicity.
• Specific for Aspergillus.
10023
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Development Stage
National Institutes of Health
• In vivo data available (animal).
Inventors: Peter R. Williamson
(NIAID), Dale O. Kiesewetter (NIBIB),
John C. Panepinto (University of
Buffalo), and Jin Qiu (NIAID).
National Cancer Institute; Notice of
Closed Meetings
Dated: February 3, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Publications
sradovich on DSK3GMQ082PROD with NOTICES
1. Palmer GE, et al., The diverse roles
of autophagy in medically important
fungi, Autophagy. 2008 Nov; 4(8):982–8.
[PMID 18927489]
2. Panepinto JC, et al., Deletion of the
Aspergillus fumigatus gene encoding
the Ras-related protein RhbA reduces
virulence in a model of invasive
pulmonary aspergillosis, Infect Immun.
2003 May; 71(5):2819–26. [PMID
12704156]
3. Desoubeaux D, et al., Diagnosis of
invasive pulmonary aspergillosis:
Updates and recommendations, Med
Mal Infect. 2014 Mar; 44(3):89–101.
[PMID 24548415]
Intellectual Property: HHS Reference
Nos. E–449–2013/0,1—U.S. Provisional
Application No. 61/894,754, filed
October 23, 2013; PCT Application No.
PCT/US2014/061917, filed October 23,
2014 (published as WO 2015/061540 on
April 30, 2015); European Application
No. 14800182.9, filed October 23, 2014
(pending); Australian Application No.
2014340035, filed October 23, 2014
(pending); Canadian Application No.
2927952, filed October 23, 2014; and
U.S. Application No. 15/030,554, filed
April 19, 2016 (pending).
Licensing Contact: Dr. David Yang,
240–627–3413; polung.yang@nih.gov.
Collaborative Research Opportunity:
The National Institute of Allergy and
Infectious Diseases is seeking statements
of capability or interest from parties
interested in collaborative research to
further develop, evaluate or
commercialize for development of this
invention. For collaboration
opportunities, please contact Dr. David
Yang, 240–627–3413; polung.yang@
nih.gov.
Dated: February 6, 2017.
Suzanne Frisbie,
Deputy Director, Technology Transfer and
Intellectual Property Office, National Institute
of Allergy and Infectious Diseases.
[FR Doc. 2017–02674 Filed 2–8–17; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:11 Feb 08, 2017
Jkt 241001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the Board of
Scientific Counselors for Basic Sciences,
National Cancer Institute and the Board
of Scientific Counselors for Clinical
Sciences and Epidemiology, National
Cancer Institute.
The meetings will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Clinical Sciences and
Epidemiology, National Cancer Institute.
Date: March 6, 2017.
Time: 8:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, C–Wing, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D.,
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center Drive, Room
3W414, Bethesda, MD 20892, 240–276–5664,
wojcikb@mail.nih.gov.
Name of Committee: Board of Scientific
Counselors for Basic Sciences, National
Cancer Institute.
Date: March 7, 2017.
Time: 9:00 a.m. to 12:15 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, C–Wing, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad Tondravi, Ph.D.,
Chief, Institute Review Office, Office of the
Director, National Cancer Institute, National
Institutes of Health, 9609 Medical Center
Drive, Room 3W–302, Bethesda, MD 20892,
240–276–5664, tondravim@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
PO 00000
Frm 00041
Fmt 4703
Sfmt 9990
[FR Doc. 2017–02615 Filed 2–8–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: March 6, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Kelly Y. Poe, Ph.D.,
Scientific Review Office, Scientific Review
Program, Division of Extramural Activities,
Room 3F40B, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5036,
poeky@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 3, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02620 Filed 2–8–17; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\09FEN1.SGM
09FEN1
Agencies
[Federal Register Volume 82, Number 26 (Thursday, February 9, 2017)]
[Notices]
[Page 10023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02620]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
Date: March 6, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Kelly Y. Poe, Ph.D., Scientific Review Office,
Scientific Review Program, Division of Extramural Activities, Room
3F40B, National Institutes of Health, NIAID, 5601 Fishers Lane, MSC
9823, Bethesda, MD 20892-9823, (240) 669-5036, poeky@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February 3, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02620 Filed 2-8-17; 8:45 am]
BILLING CODE 4140-01-P